Seeking Alpha

Tranzyme Pharma (TZYM) announced that its CFO, Richard Eisenstadt, is resigning effective...

Tranzyme Pharma (TZYM) announced that its CFO, Richard Eisenstadt, is resigning effective January 4, 2013, to pursue a new career opportunity. Upon that date, TZYM's controller, Rhonda Stanley, will assume the duties of principal financial officer and principal accounting officer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|